Search research articles
Contact Us
Filters
Showing results (111-120 of 183) with videos related to
Page
of 19
Sort By:
Obesity Facts
|
July 24, 2020
Fitness, Strength and Body Composition during Weight Loss in Women with Clinically Severe Obesity: A Randomised Clinical Trial
Clint T Miller, Steve F Fraser, Steve E Selig, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
June 2, 2007
Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk
Tye Dawood, Elisabeth A Lambert, David A Barton, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
December 12, 2018
Renal nerves contribute to hypertension in Schlager BPH/2J mice
Cindy Gueguen, Kristy L Jackson, Francine Z Marques, et al.
Journal of Behavioral Medicine
|
November 22, 2022
Mental health and quality of life during weight loss in females with clinically severe obesity: a randomized clinical trial
Daniel J van den Hoek, Clint T Miller, Steve F Fraser, et al.
Journal of the American Society of Nephrology : JASN
|
May 19, 2012
Renal denervation in moderate to severe CKD
Dagmara Hering, Felix Mahfoud, Antony S Walton, et al.
Journal of Hypertension
|
September 22, 2007
Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?
David A Barton, Tye Dawood, Elisabeth A Lambert, et al.
Heart, Lung & Circulation
|
April 2, 2019
Major Device-Dependence of Measured Hypertensive Status From 24-Hour Ambulatory Blood Pressure Monitoring After Aortic Coarctation Repair
Melissa G Y Lee, Jonathan P Mynard, Taryn L Luitingh, et al.
Diabetes, Obesity & Metabolism
|
August 22, 2025
Interrupting prolonged sitting reduces postprandial GIP but not GLP-1 responses in type 2 diabetes
Beth K Logan, Robyn Larsen, Julian W Sacre, et al.
International Journal of Molecular Sciences
|
April 30, 2021
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation
Revathy Carnagarin, Kearney Tan, Leon Adams, et al.
Metabolism: Clinical and Experimental
|
April 2, 2015
Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome
Nora E Straznicky, Mariee T Grima, Carolina I Sari, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 183) with videos related to
Sort By:
Page
of 19
Obesity Facts
|
July 24, 2020
Fitness, Strength and Body Composition during Weight Loss in Women with Clinically Severe Obesity: A Randomised Clinical Trial
Clint T Miller, Steve F Fraser, Steve E Selig, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
June 2, 2007
Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk
Tye Dawood, Elisabeth A Lambert, David A Barton, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
December 12, 2018
Renal nerves contribute to hypertension in Schlager BPH/2J mice
Cindy Gueguen, Kristy L Jackson, Francine Z Marques, et al.
Journal of Behavioral Medicine
|
November 22, 2022
Mental health and quality of life during weight loss in females with clinically severe obesity: a randomized clinical trial
Daniel J van den Hoek, Clint T Miller, Steve F Fraser, et al.
Journal of the American Society of Nephrology : JASN
|
May 19, 2012
Renal denervation in moderate to severe CKD
Dagmara Hering, Felix Mahfoud, Antony S Walton, et al.
Journal of Hypertension
|
September 22, 2007
Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?
David A Barton, Tye Dawood, Elisabeth A Lambert, et al.
Heart, Lung & Circulation
|
April 2, 2019
Major Device-Dependence of Measured Hypertensive Status From 24-Hour Ambulatory Blood Pressure Monitoring After Aortic Coarctation Repair
Melissa G Y Lee, Jonathan P Mynard, Taryn L Luitingh, et al.
Diabetes, Obesity & Metabolism
|
August 22, 2025
Interrupting prolonged sitting reduces postprandial GIP but not GLP-1 responses in type 2 diabetes
Beth K Logan, Robyn Larsen, Julian W Sacre, et al.
International Journal of Molecular Sciences
|
April 30, 2021
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation
Revathy Carnagarin, Kearney Tan, Leon Adams, et al.
Metabolism: Clinical and Experimental
|
April 2, 2015
Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome
Nora E Straznicky, Mariee T Grima, Carolina I Sari, et al.
Page
of 19